Press Releases

GlobeNewswire, Inc.

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) (NASDAQ: ODD), today announced that it will release its first quarter 2026 financial results before the market open on Tuesday, June 2, 2026, to be followed by a conference...

GlobeNewswire, Inc.

Phase 3 AD trial: 85% of patients enrolled; full enrollment on track in summer 2026 PD open-label extension (OLE) study: 40% of patients enrolled; full enrollment on track in fourth quarter 2026 New Drug Application (NDA) for buntanetap as a...

City of Boston

National recognition highlights Boston’s leadership in preserving affordable housing and preventing displacement.

City of Boston

This week, the Council approved a series of grants that will bring significant investments into programs supporting arts and culture, seniors, youth services, public safety, workforce development, climate resilience, and economic opportunity...

GlobeNewswire, Inc.

Enhanced the company’s portfolio with an exclusive license for, CUE-221, a Phase 2 program targeting allergic disease Hosted virtual R&D day showcasing CUE-401, a bifunctional IL-2 and TGF-B program targeting autoimmune disease Strengthened the...

EIN Presswire

BOSTON, MA, UNITED STATES, May 18, 2026 /⁨EINPresswire.com⁩/ -- ScribeEMR, a leading provider of AI-powered healthcare documentation solutions, including AI and virtual scribing, coding and medical office services, will exhibit at the National...

GlobeNewswire, Inc.

ALTAVISTA, Va., May 14, 2026 (GLOBE NEWSWIRE) -- Pinnacle Bankshares Corporation (“Pinnacle” or the “Company”) (OTCQX: PPBN), the one-bank holding company for First National Bank (the “Bank”), announced today that its Board of Directors declared a...

GlobeNewswire, Inc.

PHILADELPHIA, May 14, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics...

EIN Presswire

New live-online program equips senior finance executives with the leadership, communication, and strategic capabilities required to lead modern organizations.

GlobeNewswire, Inc.

Presented new data on CLD-401 at the AACR conference in San Diego, CA, detailing the profound immune changes in the tumor microenvironment induced by CLD-401; IND filing for CLD-401 expected by end of 2026 Presented new data on RedTail at the AACR...

GlobeNewswire, Inc.

Rolling submission of Biologics License Agreement (BLA) to U.S. Food and Drug Administration (FDA) seeking ST-920 approval is in progress.

GlobeNewswire, Inc.

Enrollment completed in ML-007C-MA’s Phase 2 ZEPHYR trial in schizophrenia, with topline results expected by mid-August 2026 Last patient visit completed for ML-004’s Phase 2 IRIS trial in autism spectrum disorder, with topline results expected by...

GlobeNewswire, Inc.

Boston, Massachusetts, May 14, 2026 (GLOBE NEWSWIRE) -- HYCU, Inc., the #1 AI Resilience company, today announced HYCU® aiR™ (AI Resilience), an AI-native solution that turns backup data across dozens of applications into a live and actionable...

GlobeNewswire, Inc.

Updated positive data from iadademstat in 1L AML unfit patients to be presented at EHA, with 100% ORR, 93% CRc and 79% strict CR at abstract submission cut-off Positive updated data from iadademstat in relapsed/refractory FLT3-mut AML also...

GlobeNewswire, Inc.

BOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Acquia today announced the Fair Trade Initiative, a commitment that directs 2% of every revenue-driven transaction closed with a partner to the Drupal Association, credited in the partner’s name.

GlobeNewswire, Inc.

Recent transition to the Full Market Release has already resulted in increased revenue for the current Q2, which has already exceeded Q1 revenue, as utilization and adoption of the LIBERTY System accelerates across multiple sales territories...

GlobeNewswire, Inc.

CANTON, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and shoes, announced today it will release its first quarter of fiscal 2026 financial...

GlobeNewswire, Inc.

Late-breaking abstract for BB-301 presented at the Muscular Dystrophy Association (MDA) Clinical and Scientific Conference in March demonstrated durable responses to low dose BB-301 at 12-months and 24-months post-treatment and further...

GlobeNewswire, Inc.

Updated micvotabart pelidotin (MICVO) Phase 1 monotherapy data in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) on track for mid-year 2026; update to include analyses focused on patients treated at or below a dose cap...

GlobeNewswire, Inc.

EINDHOVEN, The Netherlands, May 19, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord...